Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 05/11/15 → 03/29/18 |
Funding
- Portola Pharmaceuticals: $20,933.00
Prospective, Open-Label Study fo Andexanet Alfa in Patients Receiving a Factor Xa Inhibitor Who Have Acute Major Bleeding
- Singer, Adam (PI)
- Wright, Brian (CoPI)
- Weingart, Scott (CoPI)
Project: Research